Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2022

28-04-2022 | Type 1 Diabetes | Original Article

Prenatal and early life factors and type 1 diabetes

Authors: Alexia G. Abela, Stephen Fava

Published in: Endocrine | Issue 1/2022

Login to get access

Abstract

Background

The prevalence of type 1 diabetes is increasing worldwide, suggesting that unknown environmental factors are becoming increasingly important in its pathogenesis.

Aim

The aim of the study was to investigate the possible role of a number of prenatal and perinatal factors in the aetiology of type 1 diabetes.

Methods

Mothers of patients diagnosed with type 1 diabetes (cases) and mothers of children born on the same day and of the same sex as type 1 diabetes patients (controls) were interviewed on a number of prenatal and perinatal factors of interest.

Results

Hand washing prior to eating, frequency of bathing and total stress score were found to be positively associated with the development of type 1 diabetes on univariate analyses. Hand-washing prior to eating and frequency of house cleaning were independently associated with an increased risk of type 1 diabetes, whilst getting dirty was associated with a reduced risk in multivariate analyses. There was no association of type 1 diabetes to removing of outdoor shoes indoors or to the age of first attendance to school or pre-school. There were also no significant associations to parental smoking, parental age, birth order, infant feeding, antibiotic use, mode of delivery or birth weight.

Conclusion

Our data suggest that factors that affect the skin or gut microbiome might be more important than infections or factors affecting the microbiome at other sites.
Literature
1.
P. Onkamo, S. Vaananen, M. Karvonen, J. Tuomilehto, Worldwide increase in incidence of Type I diabetes–the analysis of the data on published incidence trends. Diabetologia 42, 1395–403 (1999)PubMedCrossRef
2.
C.C. Patterson, G.G. Dahlquist, E. Gyürüs, A. Green, G. Soltész; EURODIAB Study Group, Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373(9680), 2027–2033 (2009)PubMedCrossRef
3.
4.
R.A. Oram, A.G. Jones, R.E. Besser, B.A. Knight, B.M. Shields, R.J. Brown, A.T. Hattersley, T.J. McDonald, The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57, 187–91 (2014). Erratum in: Diabetologia. 2014;57:262PubMedCrossRef
5.
G.D. Ogle, S. James, D. Dabelea, C. Pihoker, J. Svennson, J. Maniam, E.L. Klatman, C.C. Patterson, Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th Edition. Diabetes Res Clin. Pr. 7, 109083 (2021)
6.
C.C. Patterson, S. Karuranga, P. Salpea, P. Saeedi, G. Dahlquist, G. Soltesz, G.D. Ogle, Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin. Pr. 157, 107842 (2019)CrossRef
7.
S.J. Livingstone, H.C. Looker, E.J. Hothersall, S.H. Wild, R.S. Lindsay, J. Chalmers, S. Cleland, G.P. Leese, J. McKnight, A.D. Morris, D.W. Pearson, N.R. Peden, J.R. Petrie, S. Philip, N. Sattar, F. Sullivan, H.M. Colhoun, Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med. 9(10), e1001321 (2012)PubMedPubMedCentralCrossRef
8.
A. Tran-Duy, J. Knight, P.M. Clarke, A.M. Svensson, B. Eliasson, A.J. Palmer, Development of a life expectancy table for individuals with type 1 diabetes. Diabetologia 64, 2228–2236 (2021)PubMedPubMedCentralCrossRef
9.
M. Sussman, J. Benner, M.J. Haller, M. Rewers, R. Griffiths, Estimated lifetime economic burden of type 1 diabetes. Diabetes Technol. Ther. 22(2), 121–130 (2020)PubMedCrossRef
10.
S. Fourlanos, M.D. Varney, B.D. Tait, G. Morahan, M.C. Honeyman, P.G. Colman, L.C. Harrison, The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31, 1546–9 (2008)PubMedPubMedCentralCrossRef
11.
J. Ilonen, A. Hammais, A.P. Laine, J. Lempainen, O. Vaarala, R. Veijola, O. Simell, M. Knip, Patterns of β-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 62, 3636–40 (2013)PubMedPubMedCentralCrossRef
12.
E.Z. Giannopoulou, C. Winkler, R. Chmiel, C. Matzke, M. Scholz, A. Beyerlein, P. Achenbach, E. Bonifacio, A.G. Ziegler, Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia 58, 2317–23 (2015)PubMedCrossRef
13.
14.
A.G. Abela, S. Fava, Association of incidence of type 1 diabetes with mortality from infectious disease and with antibiotic susceptibility at a country level. Acta Diabetol. 50, 859–65 (2013)PubMedCrossRef
15.
A.G. Abela, S. Fava, Does the level of bacterial exposure in early life impact the risk of Type 1 diabetes? Expert Rev. Clin. Immunol. 9, 695–7 (2013)PubMedCrossRef
16.
A.G. Abela, S. Fava, Why is the incidence of type 1 diabetes increasing? Curr. Diabetes Rev. 17, e030521193110 (2021)PubMedCrossRef
17.
Y. Vandenplas, V.P. Carnielli, J. Ksiazyk, M.S. Luna, N. Migacheva, J.M. Mosselmans, J.C. Picaud, M. Possner, A. Singhal, M. Wabitsch, Factors affecting early-life intestinal microbiota development. Nutrition 78, 110812 (2020)PubMedCrossRef
18.
R.R. Goldacre, Associations between birthweight, gestational age at birth and subsequent type 1 diabetes in children under 12: a retrospective cohort study in England, 1998-2012. Diabetologia 61, 616–625 (2018)PubMedCrossRef
19.
T.H. Holmes, R.H. Rahe, The social readjustment rating scale. J. Psychosom. Res. 11, 213–8 (1967)PubMedCrossRef
20.
21.
E.A. Gale, The rise of childhood type 1 diabetes in the 20th century. Diabetes 51, 3353–61 (2002)PubMedCrossRef
22.
23.
M. Caputo, B. Zoch-Lesniak, A. Karch, M. Vital, F. Meyer, F. Klawonn, A. Baillot, D.H. Pieper, R.T. Mikolajczyk, Bacterial community structure and effects of picornavirus infection on the anterior nares microbiome in early childhood. BMC Microbiol. 19, 1 (2019)PubMedPubMedCentralCrossRef
24.
C.R. Cardwell, D.J. Carson, C.C. Patterson, No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database. Diabet. Med. 25, 261–7 (2008)PubMedCrossRef
25.
26.
A.J. Probst, A.K. Auerbach, C. Moissl-Eichinger, Archaea on human skin. PloS One 8, 6 (2013)
27.
S. Leininger, T. Urich, M. Schloter, L. Schwark, J. Qi, G.W. Nicol, J.I. Prosser, S.C. Schuster, C. Schleper, Archaea predominate among ammonia-oxidizing prokaryotes in soils. Nature 442(7104), 806–9 (2006)PubMedCrossRef
28.
M.M.M. Kuypers, H.K. Marchant, B. Kartal, The microbial nitrogen-cycling network. Nat. Rev. Microbiol. 16, 263–276 (2018)PubMedCrossRef
29.
S. Shiva, Nitrite: a physiological store of nitric oxide and modulator of mitochondrial function. Redox Biol. 2013(1), 40–44 (2013)CrossRef
30.
A. García-Ortiz, J.M. Serrador, Nitric oxide signaling in T cell-mediated immunity. Trends Mol. Med 24, 412–427 (2018)PubMedCrossRef
31.
Y. Jianjun, R. Zhang, G. Lu, Y. Shen, L. Peng, C. Zhu, M. Cui, W. Wang, P. Arnaboldi, M. Tang, M. Gupta, C.F. Qi, P. Jayaraman, H. Zhu, B. Jiang, S.H. Chen, J.C. He, A.T. Ting, M.M. Zhou, V.K. Kuchroo, H.C. Morse III, K. Ozato, A.G. Sikora, H. Xiong, T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation. J. Exp. Med. 210, 1447–62 (2013)CrossRef
32.
S. Romagnani, T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85, 9–18 (2000). quiz 18, 21PubMedCrossRef
33.
P. Fasching, M. Stradner, W. Graninger, C. Dejaco, J. Fessler, Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders. Molecules 22, 134 (2017)PubMedCentralCrossRef
34.
P. Kumar, G. Subramaniyam, Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes. Cytokine 71, 366–76 (2015)PubMedCrossRef
35.
B.J. Oleson, K.A. Broniowska, A. Naatz, N. Hogg, V.L. Tarakanova, J.A. Corbett, Nitric oxide suppresses β-cell apoptosis by inhibiting the DNA damage response. Mol. Cell Biol. 36(15), 2067–77 (2016)PubMedPubMedCentralCrossRef
36.
N. Fierer, M. Hamady, C.L. Lauber, R. Knight, The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc. Natl. Acad. Sci. 105, 17994–17999 (2008)PubMedPubMedCentralCrossRef
37.
S.L. Edmonds-Wilson, N.I. Nurinova, C.A. Zapka, N. Fierer, M. Wilson, Review of human hand microbiome research. J. Dermatological Sci. 80, 3–12 (2015)CrossRef
38.
C.T. Brown, A.G. Davis-Richardson, A. Giongo, K.A. Gano, D.B. Crabb, N. Mukherjee, G. Casella, J.C. Drew, J. Ilonen, M. Knip, H. Hyöty, R. Veijola, T. Simell, O. Simell, J. Neu, C.H. Wasserfall, D. Schatz, M.A. Atkinson, E.W. Triplett, Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 6(10), e25792 (2011)PubMedPubMedCentralCrossRef
39.
G.A. Rook, Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health. Proc. Natl. Acad. Sci. 110, 18360–18367 (2013)PubMedPubMedCentralCrossRef
40.
P. Hemarajata, J. Versalovic, Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therapeutic Adv. Gastroenterol. 6, 39–51 (2013)CrossRef
41.
R.R. Dunn, N. Fierer, J.B. Henley, J.W. Leff, H.L. Menninger, Home life: factors structuring the bacterial diversity found within and between homes. PLoS One 8, e64133 (2013)PubMedPubMedCentralCrossRef
42.
A.M. Womack, B.J. Bohannan, J.L. Green, Biodiversity and biogeography of the atmosphere. Philos. Trans. R. Soc. B Biol. Sci. 365(1558), 3645–3653 (2010)CrossRef
43.
44.
45.
A. Tsatsoulis, The role of stress in the clinical expression of thyroid autoimmunity. Ann. NY Acad. Sci. 1088, 382–95 (2006)PubMedCrossRef
46.
G.E. Miller, M.L. Murphy, R. Cashman, R. Ma, J. Ma, J.M. Arevalo, M.S. Kobor, S.W. Cole, Greater inflammatory activity and blunted glucocorticoid signaling in monocytes of chronically stressed caregivers. Brain Behav. Immun. 41, 191–9 (2014)PubMedPubMedCentralCrossRef
47.
E.K. Grishman, P.C. White, R.C. Savani, Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes. Pediatr. Res. 71(6), 626–632 (2012)PubMedCrossRef
48.
Y.L. Chen, Y.C. Qiao, Y.H. Pan, Y. Xu, Y.C. Huang, Y.H. Wang, L.J. Geng, H.L. Zhao, X.X. Zhang, Correlation between serum interleukin-6 level and type 1 diabetes mellitus: a systematic review and meta-analysis. Cytokine 94, 14–20 (2017)PubMedCrossRef
49.
S.U. Thorsen, C.B. Pipper, S. Eising, K. Skogstrand, D.M. Hougaard, J. Svensson, F. Pociot, Neonatal levels of adiponectin, interleukin-10 and interleukin-12 are associated with the risk of developing type 1 diabetes in childhood and adolescence: a nationwide Danish case-control study. Clin. Immunol. 174, 18–23 (2017)PubMedCrossRef
50.
M.H. Blotta, R.H. DeKruyff, D.T. Umetsu, Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158, 5589–5595 (1997)PubMed
51.
M. Rachmiel, O. Bloch, A.A. Shaul, G. Ben-Yehudah, Z. Bistritzer, N. Weintrob, R. Ofan, M.J. Rapoport, Young patients with both type 1 diabetes mellitus and asthma have a unique IL-12 and IL-18 secretory pattern. Pediatr. Diabetes 12, 596–603 (2011)PubMedCrossRef
52.
L.F. Lee, B. Xu, S.A. Michie, G.F. Beilhack, T. Warganich, S. Turley, H.O. McDevitt, The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Proc. Natl. Acad. Sci. USA 102(44), 15995–6000 (2005)PubMedPubMedCentralCrossRef
53.
Metadata
Title
Prenatal and early life factors and type 1 diabetes
Authors
Alexia G. Abela
Stephen Fava
Publication date
28-04-2022
Publisher
Springer US
Keyword
Type 1 Diabetes
Published in
Endocrine / Issue 1/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03057-0

Other articles of this Issue 1/2022

Endocrine 1/2022 Go to the issue

Original Article

Neuroendocrine neoplasms of the ovary: an analysis of clinicopathological characteristics and prognosis with a focus on histological grading

Original Article

Free fatty acids are associated with muscle dysfunction in Chinese adults with type 2 diabetes

Original Article

Prospective study on the clinical relevance of 18F-DOPA positron emission tomography/computed tomography in patients with medullary thyroid carcinoma

Original Article

High intensity focused ultrasound in the therapy of benign thyroid nodules—first German bicentric study with long-term follow-up

Original Article

The dilemma of routine testing for calcitonin thyroid nodule’s patients to detect or exclude medullary carcinoma: one single negative test should be valuable as rule-out strategy to avoid further calcitonin measurements over time

Original Article

Differentiated thyroid carcinoma in the elderly: influence of age on disease-free and overall survival
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits